COMMUNIQUÉS West-GlobeNewswire

Ventura Cannabis Releases Results of AGM; Announces Updated Plan to Become a California Cannabis Branded Product Company
23/04/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, April 23, 2019 (GLOBE NEWSWIRE) -- Ventura [...]
CohBar Announces Key Opinion Leader Conference Call and Webcast
23/04/2019
Call to feature thought leaders discussing mitochondria and mitochondrial-drived peptides as a potential source of novel therapeutics Call and webcast scheduled for May 2, 2019; 10:30-11:45am EDT MENLO PARK, Calif., [...]
Radius Health to Announce First Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, May 8, 2019
23/04/2019
WALTHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter 2019 financial results on Wednesday, May 8, 2019. The Company will host a conference [...]
LIDDS: Updated Research Report from Redeye
23/04/2019
Redeye has today released an updated research report on LIDDS covering its expanded portfolio that now also includes a project targeting Toll-like Receptors (TLR). The updated research report examines the development of [...]
Guardant Health Appoints Dr. Bahija Jallal to its Board of Directors
23/04/2019
REDWOOD CITY, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, [...]
Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C3003
23/04/2019
WOBURN, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
ARCA biopharma Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial
23/04/2019
Steering Committee to Provide Scientific Oversight and Guidance for Pivotal Phase 3 Trial Evaluating Gencaro as Potentially the First Genetically-Targeted Treatment for Atrial Fibrillation WESTMINSTER, Colo., April 23, [...]
Pascal Biosciences Provides Corporate Update for First Quarter of 2019
23/04/2019
VANCOUVER, British Columbia and SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. ( TSX.V:PAS ) (“Pascal” or the “Company”), a drug discovery and development company, today provided a corporate update [...]
AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30
23/04/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, April 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
23/04/2019
Treatment with Nomacopan (Coversin) in three patients with mild-to-moderate bullous pemphigoid resulted in no drug-related adverse events and rapid reduction in Bullous Pemphigoid Disease Area Index (BPDAI) global score [...]
ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation
23/04/2019
MONTREAL, April 23, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, [...]
Japan Cell Therapy Transaction Yields $3MM
23/04/2019
Strategic focus on building a leading oncology company; Two transactions this month yielding $7MM SAN DIEGO, April 23, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today [...]
Entasis Therapeutics Strengthens Leadership Team with Appointment of Eric Kimble as Chief Commercial Officer
23/04/2019
Kimble to lead global commercialization strategy for the Company’s late-stage antimicrobial pipeline WALTHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage [...]
Nemaura Announces Successful Completion of Summative Human Factors Usability Study for SugarBEAT®
23/04/2019
Final step required prior to filing de novo application to the U.S. Food and Drug Administration Loughborough, England , April 23, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology [...]
OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement
23/04/2019
Funding Will Support OmniSeq’s Pursuit of Single-Site PMA FDA Approval for Advanced Next Generation Sequencing Oncology Panels BUFFALO, N.Y., April 23, 2019 (GLOBE NEWSWIRE) -- OmniSeq ® , a CAP-accredited, molecular [...]
Profound Medical to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Progressive Care Inc. Announces March Sales and Issues Acquisition Update
23/04/2019
MIAMI, April 23, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
Medexus CEO to Present at Two Upcoming Investor Conferences
23/04/2019
MONTREAL, April 23, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) announces that Ken d’Entremont, Chief Executive Officer, has been invited to present and [...]
Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan
23/04/2019
EAST RUTHERFORD, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]

Pages